Unknown

Dataset Information

Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer.


ABSTRACT:

Background

SPOP, an E3 ubiquitin ligase adaptor, can act either as a tumour suppressor or a tumour promoter. In prostate cancer (PCa), it inhibits tumorigenesis by degrading several oncogenic substrates. SPOP is the most altered gene in PCa (~15%), which renders it ineffective, promoting cancer. The remaining PCa tumours, which retain WT-SPOP, still progress to castration-resistant (CRPC) stage, indicating that other critical mechanisms exist for downregulating SPOP. SPOP is reduced in ~94% of WT-SPOP-bearing prostate tumours; however, no molecular mechanism is known for its downregulation.

Methods

SPOP was identified as a direct target of LIMK2 using an innovative technique. The reciprocal relationship between SPOP and LIMK2 and its consequences on oncogenicity were analyse

SUBMITTER: Nikhil K 

PROVIDER: S-EPMC7921662 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature